Get the Stockscreener App
161.46
0.59%
0.95
After Hours:
161.46
Overview
News
Price History
Option Chain
Financials
Why JNJ Down?
Discussions
Forecast
Stock Split
Dividend History
Johnson Johnson stock is traded at $161.46, with a volume of 5.06M.
It is up +0.59% in the last 24 hours and down -2.04% over the past month.
See More
Previous Close:
$160.51
Open:
$162.18
24h Volume:
5.06M
Relative Volume:
0.85
Market Cap:
$353.35B
Revenue:
$86.58B
Net Income/Loss:
$38.02B
P/E Ratio:
11.99
EPS:
13.47
Net Cash Flow:
$19.83B
1W Performance:
+0.73%
1M Performance:
-2.04%
6M Performance:
+8.52%
1Y Performance:
+3.38%
1-Day Range:
$161.20
$162.66
1-Week Range:
$158.95
$162.66
52-Week Range:
$143.13
$168.85
Johnson Johnson Stock (JNJ) Company Profile
Name
Johnson Johnson
Sector
Industry
Phone
732-524-2455
Address
ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ
Johnson Johnson Stock (JNJ) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-23-24 | Downgrade | Daiwa Securities | Outperform → Neutral |
| May-30-24 | Resumed | Goldman | Neutral |
| Apr-18-24 | Upgrade | HSBC Securities | Hold → Buy |
| Dec-13-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-01-23 | Upgrade | UBS | Neutral → Buy |
| Oct-05-23 | Initiated | RBC Capital Mkts | Outperform |
| Sep-06-23 | Initiated | HSBC Securities | Hold |
| May-30-23 | Resumed | Citigroup | Buy |
| Mar-29-23 | Initiated | UBS | Neutral |
| Mar-01-23 | Initiated | Guggenheim | Neutral |
| Nov-18-22 | Initiated | Credit Suisse | Neutral |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-14-22 | Reiterated | BofA Securities | Neutral |
| Jun-22-22 | Initiated | Daiwa Securities | Outperform |
| May-23-22 | Resumed | SVB Leerink | Outperform |
| Apr-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Mar-16-22 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Dec-17-21 | Initiated | Goldman | Neutral |
| Dec-15-21 | Reiterated | Citigroup | Buy |
| Sep-07-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| May-28-21 | Resumed | Morgan Stanley | Overweight |
| Apr-28-20 | Downgrade | UBS | Buy → Neutral |
| Apr-22-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Dec-19-19 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-17-19 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-20-19 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-16-19 | Upgrade | Atlantic Equities | Underweight → Neutral |
| Oct-11-19 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Jul-12-19 | Resumed | Credit Suisse | Outperform |
| May-28-19 | Initiated | Goldman | Buy |
| Jan-23-19 | Reiterated | Barclays | Equal Weight |
| Jul-12-18 | Upgrade | Goldman | Sell → Neutral |
| Jun-27-18 | Initiated | Bernstein | Mkt Perform |
| Apr-23-18 | Reiterated | Citigroup | Neutral |
| Apr-18-18 | Reiterated | Stifel | Hold |
| Jan-24-18 | Reiterated | Stifel | Hold |
| Jan-12-18 | Reiterated | Wells Fargo | Outperform |
| Jan-02-18 | Downgrade | JP Morgan | Overweight → Neutral |
| Oct-18-17 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-18-17 | Reiterated | Stifel | Hold |
View All
Johnson Johnson Stock (JNJ) Latest News
Pharmacogenomics Industry Report 2024: Analysis by Technology, Application, End-user, Region, and Company with Growth Forecasts to 2032 - GlobeNewswire Inc.
What Trends Will Drive Johnson & Johnson's Q3 Results? - Forbes
What You Need To Know Ahead of Johnson & Johnson's Earnings - Investopedia
Nasal Drug Delivery Technology Industry Analysis and Opportunity Forecast, 2030Strategic Profiles of 47 Key Players in the Projected $125 Billion Market - GlobeNewswire Inc.
Proud to call New Jersey home - Johnson & Johnson
J&J talc bankruptcy stays in Texas despite 'forum-shopping' opposition - Reuters
J&J Talc Bankruptcy Stays in Texas, Boosting Settlement Odds (1) - Bloomberg Law
Browns vs. Eagles injury report - PhiladelphiaEagles.com
Inside Congress - POLITICO
Johnson slams door on Congress returning for disaster aid - POLITICO
Spanberger Urges Speaker Johnson to Call U.S. House Back to Capitol Hill to Pass Emergency Appropriations Funding Following Hurricanes Helene & Milton - Abigail Spanberger
10 takeaways from Glenn, Johnson & Fipp - detroitlions.com
Global Antiemetics Drugs Market to Exhibit Growth at a CAGR of ~6% by 2030 | DelveInsight - GlobeNewswire Inc.
Ben Johnson earns preseason All-ASUN nod - BU Athletics
Johnson & Johnson MedTech Launches VOLT™ Plating System - BioSpace
California pledged $500 million to help tenants preserve affordable housing. They didn't get a dime. - CalMatters
U.S. Laparoscopic Retrieval Bag (Detachable, Non-Detachable) Market Trends Report 2024-2030 with Competitive Analysis of Leading Payers - GlobeNewswire Inc.
Cross-code talent Alfie Johnson signs for the Wire - Warrington Wolves
Speaker Johnson’s 2020 election challenge raises questions for 2024 - The Hill
Johnson & Johnson submits application to the European Medicines Agency for DARZALEX® (daratumumab) SC-based quadruplet regimen for newly diagnosed multiple myeloma patients - GlobeNewswire Inc.
‘I felt like Achilles in a hard hat’: an extract from Boris Johnson’s ‘alternative’ memoir - The Guardian
Jeffries and Johnson plow cash into House "squinter" races - Axios
Mike Johnson Faces New Pressure As Hurricane Milton Makes Landfall - Newsweek
Wesley Johnson talks analyst role on the Gulf Coast Sports Network | Pelicans Podcast - NBA.com
‘Quiet giant’ of SD politics, Tim Johnson, dies at age 77 - South Dakota Searchlight
Supporting Transgender, Non-binary, and Gender-Expansive Children - Human Rights Campaign
Revolution team analyst William Johnson earns first call-up to U.S. Power Soccer National Team - New England Revolution
Volleyball Hosts Johnson C. Smith Thursday Night - Winston-Salem State
Amy Johnson Named Lecture 2024Lessons from an ever-changing and challenging aviation landscape - Royal Aeronautical Society
Johnson & Johnson Completes Acquisition of V-Wave - BioSpace
Johnson & Johnson completes $1.7B V-Wave acquisition - Mass Device
Germany Pharmaceuticals Market Report 2024-2028: Consolidation through Mergers and Acquisitions Catalyzing Growth - GlobeNewswire Inc.
Jets owner: Decision to fire Saleh 'mine alone' - ESPN Australia
Boris Johnson attacks 'shameful' treatment of peer Charlotte Owen - BBC.com
Boris Johnson responds to backlash and reviews of his new book - CNN
Fantasy Football Week 6: Start ‘Em Advice And Waiver Wire Rankings - Seahawks.com
What To Expect When Johnson & Johnson Reports Q3 Earnings Next Week? - Yahoo Finance
Johnson & Johnson submits new Monarch surgical robot software for FDA clearance - Mass Device
Equestrian Wins Johnson & Wales Show to Start Season - Brown University Athletics
Mulkey, Johnson and Morrow To Represent LSU At SEC Media Day - Louisiana State University Athletics
Jets fire Robert Saleh after 2-3 start; DC Jeff Ulbrich named interim head coach - NFL.com
Fatty acids found in meat and poultry may be beneficial to human metabolism - Purdue College of Agriculture News & Stories
3 Undervalued Dividend Stocks Primed for Growth in 2025 - Investing.com
Analysts Estimate Johnson & Johnson (JNJ) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Watch the BBC's Matt Chorley interview Boris Johnson - BBC.com
Forget the f-words, ignore the erections: how did an entire plane collectively choose to watch Daddio? - The Guardian
Johnson & Johnson's (NYSE:JNJ) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat? - Yahoo Finance
Johnson & Johnson discontinues Phase III study of treatment for bladder cancer - Clinical Trials Arena
‘If I have a fault, it’s that I’m too honest’ – Boris Johnson’s Unleashed, digested by John Crace - The Guardian
Bone Cement for Spine Market to Reach $168.6 Million, Globally, by 2033 at 5.3% CAGR: Allied Market Research - GlobeNewswire Inc.
Obituary | Senator Tim Johnson of Sioux Falls, South Dakota - Miller Funeral Home
Johnson Johnson Stock (JNJ) Financials Data
Revenue
Net Income
Cash Flow
EPS
Johnson Johnson Stock (JNJ) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Decker Robert J | VP Corporate Controller |
Aug 30 '24 |
Sale |
165.06 |
5,635 |
930,113 |
18,973 |
0.08%
0.30%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):